Literature DB >> 31853753

Radioprotective effect of diethylcarbamazine on radiation-induced acute lung injury and oxidative stress in mice.

Soghra Farzipour1,2, Fereshteh Talebpour Amiri3, Ehsan Mihandoust4, Fatemeh Shaki5, Zohreh Noaparast1, Arash Ghasemi6, Seyed Jalal Hosseinimehr7.   

Abstract

The present study was designed to evaluate the radioprotective effect of diethylcarbamazine (DEC) against oxidative stress and acute lung injury induced by total body radiation (TBI) in mice. For study the optimum dose for radiation protection of DEC, mice were administrated with three dose of DEC (10, 50 and 100 mg/kg), once daily for eight consecutive days. Animals were exposed whole body to 5 Gy X-radiation on the 9 day. The radioprotective potential of DEC in lung tissues was assessed using oxidative stress examinations at 24 h after TBI and histopathological assay also was analyzed one week after TBI. Results from biochemical analyses demonstrated increased malonyldialdehyde (MDA), nitric oxide (NO) and protein carbonyl (PC) levels of lung tissues in only irradiated group. Histopathologic findings also showed an increase in the number of inflammatory cells and the acute lung injury in this group. DEC pretreatment significantly mitigated the oxidative stress biomarkers as well as histological damages in irradiated mice. The favorable radioprotective effect against lungs injury was observed at a dose of 10 mg/kg of DEC in mice as compared with two other doses (50 and 100 mg/kg). The data of this study showed that DEC at a dose of 10 mg/kg with having antioxidant and anti-inflammatory properties can be used as a therapeutic candidate for protecting the lung from radiation-induced damage.

Entities:  

Keywords:  Diethylcarbamazine; Ionizing radiation; Lung injury; Oxidative stress

Mesh:

Substances:

Year:  2019        PMID: 31853753     DOI: 10.1007/s10863-019-09820-9

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  45 in total

1.  Role of crosslinked protein in lung injury following total body irradiation and bone marrow transplantation.

Authors:  Soo Young Lee; Young Jin Kim; Yeun Jung Kim
Journal:  Exp Mol Med       Date:  2003-12-31       Impact factor: 8.718

Review 2.  Pharmacological control of asthma.

Authors:  A F Wilson; J J McPhillips
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

Review 3.  The Role of NF-kB Inhibitors in Cell Response to Radiation.

Authors:  Sajjad Molavi Pordanjani; Seyed Jalal Hosseinimehr
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

4.  Protective effect of diethylcarbamazine inhibits NF-κB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway.

Authors:  Guowei Jia; Ming Zao; Xiaoyu Liu
Journal:  Mol Med Rep       Date:  2017-06-06       Impact factor: 2.952

5.  Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker.

Authors:  A Molteni; J E Moulder; E F Cohen; W F Ward; B L Fish; J M Taylor; L F Wolfe; L Brizio-Molteni; P Veno
Journal:  Int J Radiat Biol       Date:  2000-04       Impact factor: 2.694

6.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

7.  Diethylcarbamazine inhibits NF-κB activation in acute lung injury induced by carrageenan in mice.

Authors:  Laise Aline Martins Santos; Edlene Lima Ribeiro; Karla Patrícia Sousa Barbosa; Ingrid Tavares Fragoso; Fabiana Oliveira Dos Santos Gomes; Mariana Aragão Matos Donato; Bruna Santos Silva; Amanda Karolina Soares Silva; Sura Wanessa Santos Rocha; Maria Eduarda Rocha França; Gabriel Barros Rodrigues; Teresinha Gonçalves Silva; Christina Alves Peixoto
Journal:  Int Immunopharmacol       Date:  2014-08-28       Impact factor: 4.932

Review 8.  Anti-inflammatory effects of diethylcarbamazine: a review.

Authors:  Christina Alves Peixoto; Bruna Santos Silva
Journal:  Eur J Pharmacol       Date:  2014-04-12       Impact factor: 4.432

9.  IL-13 is a therapeutic target in radiation lung injury.

Authors:  Su I Chung; Jason A Horton; Thirumalai R Ramalingam; Ayla O White; Eun Joo Chung; Kathryn E Hudak; Bradley T Scroggins; Joseph R Arron; Thomas A Wynn; Deborah E Citrin
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

10.  Nebulisation of synthetic lamellar lipids mitigates radiation-induced lung injury in a large animal model.

Authors:  David Collie; John T Murchison; Steven H Wright; Alec McLean; Lynsey Howard; Jorge Del-Pozo; Sionagh Smith; Gerry McLachlan; Jessica Lawrence; Elaine Kay; Tobias Schwarz; Magdalena Parys
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

View more
  2 in total

Review 1.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

2.  Role and Mechanism of Maresin-1 in Acute Lung Injury Induced by Trauma-Hemorrhagic Shock.

Authors:  Huayi Ma; Song Mo; Qushen Yi; Junhua Lai; Huan Liu; Zhanying Shi
Journal:  Med Sci Monit       Date:  2020-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.